| Profiles RNS

Profile

MD, University of Athens

Websites

	LinkedIn
	Boston Medical Center Physician Provider Profile
	ResearchGate
	Prostate Cancer Foundation

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Tijaro-Ovalle NM, Karantanos T, Wang HT, Boussiotis VA. Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease. Front Immunol. 2019; 10:295. PMID: 30891031

Karantanos T, Jones RJ. Acute Myeloid Leukemia Stem Cell Heterogeneity and Its Clinical Relevance. Adv Exp Med Biol. 2019; 1139:153-169. PMID: 31134500

Karantanos T, Rooper L, Kang Y, Lin CT, Wenga P, Sagorsky S, Lauring J, Kang H. Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1-Deficient Carcinoma. Oncologist. 2019 02; 24(2):146-150. PMID: 30297384

Rooper LM, Karantanos T, Ning Y, Bishop JA, Gordon SW, Kang H. Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity. Am J Surg Pathol. 2018 08; 42(8):1121-1126. PMID: 29683815

Karantanos T, Karanika S, Seth B, Gignac G. The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study. Clin Transl Oncol. 2019 Feb; 21(2):206-212.View Related Profiles.

Gignac, Gretchen
Karantanos, Theodoros

PMID: 29948974

Karantanos T, Moliterno AR. The roles of JAK2 in DNA damage and repair in the myeloproliferative neoplasms: Opportunities for targeted therapy. Blood Rev. 2018 09; 32(5):426-432. PMID: 29627078

Li L, Karanika S, Yang G, Wang J, Park S, Broom BM, Manyam GC, Wu W, Luo Y, Basourakos S, Song JH, Gallick GE, Karantanos T, Korentzelos D, Azad AK, Kim J, Corn PG, Aparicio AM, Logothetis CJ, Troncoso P, Heffernan T, Toniatti C, Lee HS, Lee JS, Zuo X, Chang W, Yin J, Thompson TC. Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer. Sci Signal. 2017 May 23; 10(480). PMID: 28536297

Karantanos T, Politikos I, Boussiotis VA. Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies. Blood Lymphat Cancer. 2017; 7:37-52. PMID: 28701859

Karanika S, Karantanos T, Li L, Wang J, Park S, Yang G, Zuo X, Song JH, Maity SN, Manyam GC, Broom B, Aparicio AM, Gallick GE, Troncoso P, Corn PG, Navone N, Zhang W, Li S, Thompson TC. Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling. Cell Rep. 2017 02 21; 18(8):1970-1981. PMID: 28228262

Elias R, Karantanos T, Sira E, Hartshorn KL. Immunotherapy comes of age: Immune aging & checkpoint inhibitors. J Geriatr Oncol. 2017 May; 8(3):229-235.View Related Profiles.

Hartshorn, Kevan
Karantanos, Theodoros

PMID: 28223073; DOI: 10.1016/j.jgo.2017.02.001;

Showing 10 of 47 results. Show More

Christofides A, Karantanos T, Bardhan K, Boussiotis VA. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2. Oncotarget. 2016 Dec 20; 7(51):85624-85640. PMID: 27793053

Karantanos T, Boussiotis VA. JAK3-mediated phosphorylation of EZH2: a novel mechanism of non-canonical EZH2 activation and oncogenic function. Transl Cancer Res. 2016 Nov; 5(Suppl 6):S1208-S1211. PMID: 28868240

Politikos I, T Kim H, Karantanos T, Brown J, McDonough S, Li L, Cutler C, Antin JH, Ballen KK, Ritz J, Boussiotis VA. Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults. Biol Blood Marrow Transplant. 2017 Jan; 23(1):103-112. PMID: 27777141

Karantanos T, Christofides A, Bardhan K, Li L, Boussiotis VA. Corrigendum: Regulation of T Cell Differentiation and Function by EZH2. Front Immunol. 2016; 7:346. PMID: 27648006

Karantanos T, Karanika S, Gignac G. Uncontrolled diabetes predicts poor response to novel antiandrogens. Endocr Relat Cancer. 2016 Sep; 23(9):691-8.View Related Profiles.

Gignac, Gretchen
Karantanos, Theodoros

PMID: 27515296; DOI: 10.1530/ERC-16-0222;

Karantanos T, Karanika S, Obiokoye K, Sullivan M, Phillips C, Ananthakrishnan S. Pyogenic Liver Abscess Due to Fusobacterium nucleatum in a Patient With Liver Hemangiomas. Am J Med Sci. 2017 Apr; 353(4):417-418.View Related Profiles.

Phillips, Christine
Sullivan, Margaret
Ananthakrishnan, Sonia
Karantanos, Theodoros

PMID: 28317637; DOI: 10.1016/j.amjms.2016.07.008;

Karantanos T, Karanika S, Wang J, Yang G, Dobashi M, Park S, Ren C, Li L, Basourakos SP, Hoang A, Efstathiou E, Wang X, Troncoso P, Titus M, Broom B, Kim J, Corn PG, Logothetis CJ, Thompson TC. Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer. Oncotarget. 2016 Jul 19; 7(29):46321-46334. PMID: 27331874

Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E. Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis. Clin Infect Dis. 2016 Aug 01; 63(3):310-8. PMID: 27143671

Karantanos T, Chistofides A, Barhdan K, Li L, Boussiotis VA. Regulation of T Cell Differentiation and Function by EZH2. Front Immunol. 2016; 7:172. PMID: 27199994; PMCID: PMC4853381

Karantanos T, Karanika S. Assessing the cardiovascular risk of hormonal therapy in patients with prostate cancer. Ann Transl Med. 2016 Mar; 4(5):99. PMID: 27047958; PMCID: PMC4791328

Theodoropoulos GE, Memos NA, Peitsidou K, Karantanos T, Spyropoulos BG, Zografos G. Synbiotics and gastrointestinal function-related quality of life after elective colorectal cancer resection. Ann Gastroenterol. 2016 Jan-Mar; 29(1):56-62. PMID: 26752951; PMCID: PMC4700848

Karanika S, Karantanos T, Kurosaka S, Wang J, Hirayama T, Yang G, Park S, Golstov AA, Tanimoto R, Li L, Thompson TC. GLIPR1-?TM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells. Mol Cancer. 2015 Jun 19; 14:122. PMID: 26084402; PMCID: PMC4484888

Karanika S, Karantanos T, Yin J, Li L, Thompson TC. Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistance. Asian J Urol. 2014 Oct; 1(1):30-39. PMID: 29511635

Aravantinos G, Isaakidou A, Karantanos T, Sioziou A, Theodoropoulos GE, Pektasides D, Gazouli M. Association of CD133 polymorphisms and response to bevacizumab in patients with metastatic colorectal cancer. Cancer Biomark. 2015; 15(6):843-50. PMID: 26406410

Karantanos T, Evans CP, Tombal B, Thompson TC, Montironi R, Isaacs WB. Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level. Eur Urol. 2015 Mar; 67(3):470-9. PMID: 25306226

Karanika S, Karantanos T, Li L, Corn PG, Thompson TC. DNA damage response and prostate cancer: defects, regulation and therapeutic implications. Oncogene. 2015 May 28; 34(22):2815-22. PMID: 25132269; PMCID: PMC4333141

Li L, Chang W, Yang G, Ren C, Park S, Karantanos T, Karanika S, Wang J, Yin J, Shah PK, Takahiro H, Dobashi M, Zhang W, Efstathiou E, Maity SN, Aparicio AM, Li Ning Tapia EM, Troncoso P, Broom B, Xiao L, Lee HS, Lee JS, Corn PG, Navone N, Thompson TC. Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer. Sci Signal. 2014 May 20; 7(326):ra47. PMID: 24847116; PMCID: PMC4135429

Thomas D, Gazouli M, Karantanos T, Rigoglou S, Karamanolis G, Bramis K, Zografos G, Theodoropoulos GE. Association of rs1568885, rs1813443 and rs4411591 polymorphisms with anti-TNF medication response in Greek patients with Crohn's disease. World J Gastroenterol. 2014 Apr 07; 20(13):3609-14. PMID: 24707144; PMCID: PMC3974528

Theodoropoulos GE, Karantanos T. Quality of life after laparoscopic colectomy for cancer. JSLS. 2014 Apr-Jun; 18(2):225-35. PMID: 24960485; PMCID: PMC4035632

Karantanos T, Theodoropoulos G, Pektasides D, Gazouli M. Clock genes: their role in colorectal cancer. World J Gastroenterol. 2014 Feb 28; 20(8):1986-92. PMID: 24587674; PMCID: PMC3934468

Marinatou A, Theodoropoulos GE, Karanika S, Karantanos T, Siakavellas S, Spyropoulos BG, Toutouzas K, Zografos G. Do anastomotic leaks impair postoperative health-related quality of life after rectal cancer surgery? A case-matched study. Dis Colon Rectum. 2014 Feb; 57(2):158-66. PMID: 24401876

Karantanos T, Tanimoto R, Edamura K, Hirayama T, Yang G, Golstov AA, Wang J, Kurosaka S, Park S, Thompson TC. Systemic GLIPR1-?TM protein as a novel therapeutic approach for prostate cancer. Int J Cancer. 2014 Apr 15; 134(8):2003-13. PMID: 24590455; PMCID: PMC3942887

Karantanos T, Theodoropoulos G, Gazouli M, Vaiopoulou A, Karantanou C, Lymberi M, Pektasides D. Expression of clock genes in patients with colorectal cancer. Int J Biol Markers. 2013 Sep 27; 28(3):280-5. PMID: 23712462

Karantanos T, Theodoropoulos G, Gazouli M, Vaiopoulou A, Karantanou C, Stravopodis DJ, Bramis K, Lymperi M, Pektasidis D. Association of the clock genes polymorphisms with colorectal cancer susceptibility. J Surg Oncol. 2013 Dec; 108(8):563-7. PMID: 24037774

Karantanos T, Thompson TC. GEMMs shine a light on resistance to androgen deprivation therapy for prostate cancer. Cancer Cell. 2013 Jul 08; 24(1):11-3. PMID: 23845440; PMCID: PMC3881957

Karantanos T, Corn PG, Thompson TC. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches. Oncogene. 2013 Dec 05; 32(49):5501-11. PMID: 23752182; PMCID: PMC3908870

Karanika S, Karantanos T, Theodoropoulos GE. Immune response after laparoscopic colectomy for cancer: a review. Gastroenterol Rep (Oxf). 2013 Sep; 1(2):85-94. PMID: 24759813; PMCID: PMC3938011

Theodoropoulos GE, Papanikolaou IG, Karantanos T, Zografos G. Post-colectomy assessment of gastrointestinal function: a prospective study on colorectal cancer patients. Tech Coloproctol. 2013 Oct; 17(5):525-36. PMID: 23605189

Peitsidou K, Karantanos T, Theodoropoulos GE. Probiotics, prebiotics, synbiotics: is there enough evidence to support their use in colorectal cancer surgery?. Dig Surg. 2012; 29(5):426-38. PMID: 23258276

Theodoropoulos GE, Karantanos T, Stamopoulos P, Zografos G. Prospective evaluation of health-related quality of life after laparoscopic colectomy for cancer. Tech Coloproctol. 2013 Feb; 17(1):27-38. PMID: 23065134

Theodoropoulos GE, Michalopoulos NV, Pantou MP, Kontogianni P, Gazouli M, Karantanos T, Lymperi M, Zografos GC. Caspase 9 promoter polymorphisms confer increased susceptibility to breast cancer. Cancer Genet. 2012 Oct; 205(10):508-12. PMID: 22981751

Theodoropoulos GE, Saridakis V, Karantanos T, Michalopoulos NV, Zagouri F, Kontogianni P, Lymperi M, Gazouli M, Zografos GC. Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development. Breast. 2012 Aug; 21(4):534-8. PMID: 22560646

Markoutsaki T, Karantanos T, Gazouli M, Anagnou NP, Karamanolis DG. 5-HT2A receptor gene polymorphisms and irritable bowel syndrome. J Clin Gastroenterol. 2011 Jul; 45(6):514-7. PMID: 21325954

Markoutsaki T, Karantanos T, Gazouli M, Anagnou NP, Ladas SD, Karamanolis DG. Serotonin transporter and G protein beta 3 subunit gene polymorphisms in Greeks with irritable bowel syndrome. Dig Dis Sci. 2011 Nov; 56(11):3276-80. PMID: 21559741

Karantanos T, Gazouli M. Inflammatory bowel disease: recent advances on genetics and innate immunity. Ann Gastroenterol. 2011; 24(3):164-172. PMID: 24713780

Karantanos T, Markoutsaki T, Gazouli M, Anagnou NP, Karamanolis DG. Current insights in to the pathophysiology of Irritable Bowel Syndrome. Gut Pathog. 2010 May 13; 2(1):3. PMID: 20465787; PMCID: PMC2876056

Dassoulas K, Gazouli M, Theodoropoulos G, Christoni Z, Rizos S, Zisi-Serbetzoglou A, Glava C, Karantanos T, Klonaris C, Karakitsos P. Vascular endothelial growth factor and endoglin expression in colorectal cancer. J Cancer Res Clin Oncol. 2010 May; 136(5):703-8. PMID: 19890661

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Contact for Mentoring: